Tag: BSV
Bharat Serums & Vaccines partners Sir JJ School of Arts to...
Sanjiv Navangul, Managing Director and CEO, BSV along with Vishwanath D. Sabale, Dean, Sir JJ School of Arts, felicitated the artists
BSV expands footprint in Malaysia, to acquire Firstline Pharma & Genomicks
With the move, Bharat Serums and Vaccines Limited (BSV) aims at deepening its presence in South-East Asia
BSV partners Indian Institute of Science for research on next-gen snakebite...
Supports research of Antibodies & Antivenom development at the IISc Evolutionary Venomics Laboratory facility
BSV forges collaboration with NCL-Pune to co-develop biopharma products
This collaboration primarily focuses on evaluation of certain recombinant cell line technologies developed by NCL for biopharmaceutical products currently under development at BSV
BSV acquires key brand from Jagdale Industries
The company plans to strengthen its presence in women’s health segment
Green Energy: Bharat Serums invests in captive solar power project in...
Invests in AMP Energy C&I One Private Limited, for fulfilling solar power requirements in its manufacturing facility at Ambernath
Budget 2022: “Mention of Genomics & Pharma as sunrise opportunities is...
As the country moves towards good health and economic well-being, it is critical to continue to innovate in India and the rest of the world, says Sanjiv Navangul, Managing Director & CEO, Bharat Serums and Vaccines Limited................
Bharat Serums & Vaccines sets up its world class R&D centre...
The company's Research & Development (R&D) centre at Airoli, Maharashtra inaugurated by Rajesh Tope, Health Minister, State of Maharashtra will endeavor to bring scientifically advanced biological, biotechnology products and novel drug delivery systems that deliver better patient outcomes